Literature DB >> 21097874

Characterization of an interferon-stimulated response element (ISRE) in the Il23a promoter.

Shehzad Z Sheikh1, Taku Kobayashi, Katsuyoshi Matsuoka, Joseph C Onyiah, Scott E Plevy.   

Abstract

We have demonstrated previously that IFN-γ plays a protective role in the initiation of chronic intestinal inflammation through attenuation of Toll-like receptor-mediated IL-23 induction in macrophages. Here, an interferon-stimulated response element (ISRE) is identified in a region of conserved nucleotide sequences in the Il23a promoter. This ISRE mediated, in part, Il23a promoter induction by LPS and inhibition of LPS-induced activity by IFN-γ. LPS and IFN-γ recruit interferon regulatory factors (IRFs) to the Il23a ISRE in murine bone marrow-derived macrophages (BMMs). Functionally, IRF-1 is a negative regulator of Il23a in LPS-stimulated BMMs. IRF-1(-/-) BMMs demonstrated enhanced LPS-induced Il23a expression compared with WT BMMs. Moreover, IRF-1 deficiency resulted in prolonged occupancy of RelA on the Il23a promoter. Consequently, IRF-1(-/-) mice were more susceptible to colonic injury by trinitrobenzenesulfonic acid, and IL-10/IRF-1 double-deficient (IL-10/IRF-1(-/-)) mice demonstrated more severe colonic inflammation compared with IL-10(-/-) mice. The severity of colitis in both models correlated with increased colonic IL-23. CD11b(+) lamina propria mononuclear cells, comprising predominantly macrophages, were identified as the major source of IL-23 in colitis-prone mice. Basal and heat-killed Escherichia coli-stimulated levels of Il23a were increased in IL-10/IRF-1(-/-) compared with WT and IL-10(-/-) colonic CD11b(+) lamina propria mononuclear cells. In conclusion, these experiments characterize IRF-ISRE interactions on the Il23a promoter, which have in vivo relevance as a homeostatic checkpoint in chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097874      PMCID: PMC3020724          DOI: 10.1074/jbc.M110.147884

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Promoter analysis reveals critical roles for SMAD-3 and ATF-2 in expression of IL-23 p19 in macrophages.

Authors:  Fahd Al-Salleeh; Thomas M Petro
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.

Authors:  Laurie E Harrington; Robin D Hatton; Paul R Mangan; Henrietta Turner; Theresa L Murphy; Kenneth M Murphy; Casey T Weaver
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

3.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17.

Authors:  Heon Park; Zhaoxia Li; Xuexian O Yang; Seon Hee Chang; Roza Nurieva; Yi-Hong Wang; Ying Wang; Leroy Hood; Zhou Zhu; Qiang Tian; Chen Dong
Journal:  Nat Immunol       Date:  2005-10-02       Impact factor: 25.606

4.  Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice.

Authors:  K Vermeire; H Heremans; M Vandeputte; S Huang; A Billiau; P Matthys
Journal:  J Immunol       Date:  1997-06-01       Impact factor: 5.422

Review 5.  TNBS-colitis.

Authors:  M Neurath; I Fuss; W Strober
Journal:  Int Rev Immunol       Date:  2000       Impact factor: 5.311

6.  Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells.

Authors:  Huabao Xiong; Chen Zhu; Fengling Li; Refaat Hegazi; Kaili He; Mark Babyatsky; Anthony J Bauer; Scott E Plevy
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

7.  Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP.

Authors:  Chen Zhu; Kavitha Rao; Huabao Xiong; Khatuna Gagnidze; Fengling Li; Curt Horvath; Scott Plevy
Journal:  J Biol Chem       Date:  2003-07-22       Impact factor: 5.157

Review 8.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

9.  Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway.

Authors:  Refaat A F Hegazi; Kavitha N Rao; Aqila Mayle; Antonia R Sepulveda; Leo E Otterbein; Scott E Plevy
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

10.  Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1.

Authors:  Jianguo Liu; Shanjin Cao; Lisa M Herman; Xiaojing Ma
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more
  10 in total

Review 1.  Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer.

Authors:  Juming Yan; Mark J Smyth; Michele W L Teng
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-07-02       Impact factor: 10.005

2.  Differential effects of IFN-β on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells.

Authors:  Jui-Hung Yen; Weimin Kong; Kirsten M Hooper; Frances Emig; Kate M Rahbari; Ping-Chang Kuo; Barbara A Scofield; Doina Ganea
Journal:  J Leukoc Biol       Date:  2015-06-09       Impact factor: 4.962

Review 3.  IL-23 in infections, inflammation, autoimmunity and cancer: possible role in HIV-1 and AIDS.

Authors:  Govardhana Rao Yannam; Tanuja Gutti; Larisa Y Poluektova
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-24       Impact factor: 4.147

4.  NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis.

Authors:  Taku Kobayashi; Erin C Steinbach; Steven M Russo; Katsuyoshi Matsuoka; Tomonori Nochi; Nitsan Maharshak; Luke B Borst; Bruce Hostager; J Victor Garcia-Martinez; Paul B Rothman; Masaki Kashiwada; Shehzad Z Sheikh; Peter J Murray; Scott E Plevy
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

5.  Prostaglandin E2-induced IL-23p19 subunit is regulated by cAMP-responsive element-binding protein and C/AATT enhancer-binding protein β in bone marrow-derived dendritic cells.

Authors:  Virginia P Kocieda; Sabina Adhikary; Frances Emig; Jui-Hung Yen; Miguel G Toscano; Doina Ganea
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

6.  Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.

Authors:  Lynda Grine; Lien Dejager; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

7.  Early secreted antigenic target of 6-kDa protein of Mycobacterium tuberculosis primes dendritic cells to stimulate Th17 and inhibit Th1 immune responses.

Authors:  Xisheng Wang; Peter F Barnes; Fangfang Huang; Ivana B Alvarez; Pierre F Neuenschwander; David R Sherman; Buka Samten
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

8.  Carbon monoxide and heme oxygenase-1 prevent intestinal inflammation in mice by promoting bacterial clearance.

Authors:  Joseph C Onyiah; Shehzad Z Sheikh; Nitsan Maharshak; Erin C Steinbach; Steven M Russo; Taku Kobayashi; Lantz C Mackey; Jonathan J Hansen; Adam J Moeser; John F Rawls; Luke B Borst; Leo E Otterbein; Scott E Plevy
Journal:  Gastroenterology       Date:  2012-12-22       Impact factor: 22.682

9.  A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells.

Authors:  Silvia Yumi Bando; Priscila Iamashita; Beatriz E Guth; Luis F Dos Santos; André Fujita; Cecilia M Abe; Leandro R Ferreira; Carlos Alberto Moreira-Filho
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

10.  BET Protein Inhibition Regulates Macrophage Chromatin Accessibility and Microbiota-Dependent Colitis.

Authors:  Michelle Hoffner O'Connor; Ana Berglind; Meaghan M Kennedy Ng; Benjamin P Keith; Zachary J Lynch; Matthew R Schaner; Erin C Steinbach; Jeremy Herzog; Omar K Trad; William R Jeck; Janelle C Arthur; Jeremy M Simon; R Balfour Sartor; Terrence S Furey; Shehzad Z Sheikh
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.